Metraipolis › archive › dc_381ada9809de

CDK9 inhibitor A09-003 overcomes TRAIL resistance via dual Mcl-1 suppression in breast cancer cells — Europe PMC PMID:42084660

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42084660
DOI
10.1007/s12672-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-02T16:51:13.771Z
SHA-256 of the archived text
8c245db2f1ba1fc8158bc5f3ec6e0e731994af379c09e67d9750a2799fd0dae4
Stable URL of this page
https://metraipolis.com/documento/dc_381ada9809de

How to cite

CDK9 inhibitor A09-003 overcomes TRAIL resistance via dual Mcl-1 suppression in breast cancer cells — Europe PMC PMID:42084660 — Europe PMC (en), https://europepmc.org/article/MED/42084660 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_381ada9809de (Metraipolis archive dc_381ada9809de, sha256 8c245db2f1ba1fc8158bc5f3ec6e0e731994af379c09e67d9750a2799fd0dae4)
BibTeX
@misc{dc381ada9809de,
  title = {CDK9 inhibitor A09-003 overcomes TRAIL resistance via dual Mcl-1 suppression in breast cancer cells — Europe PMC PMID:42084660},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42084660},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_381ada9809de; sha256 8c245db2f1ba1fc8158bc5f3ec6e0e731994af379c09e67d9750a2799fd0dae4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42084660. Agents can read the archived copy with the MCP tool read_document.